Evidence map›Paper›PMID 37928526›Full record

ArticleFrontiers in immunology2023

Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction.

Satoru Mizuno, Yasushi Chuma, Yukihiro Shibuya, Shigeo Horibata, Tomoe Baba, Emi Yokokawa, Kazuhiro Matsuo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Satoru MizunoResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Yasushi ChumaResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Yukihiro ShibuyaResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Shigeo HoribataResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Tomoe BabaResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Emi YokokawaResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Kazuhiro MatsuoResearch and Development Department, Japan BCG Laboratory, Kiyose, Tokyo, Japan.
Japan BCG Laboratory · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium bovisTuberculosisAdjuvants, ImmunologicAnimalsBCG VaccineCD8-Positive T-LymphocytesMiceT-Lymphocytes, CytotoxicAdjuvants, ImmunologicBCG Vaccineculture filtrate proteincytotoxic T lymphocytesimmunotherapyMycobacterium bovis bacilli Calmette-Guerintuberculosis

Identifiers

PMID37928526
PMCPMC10622798
OpenAlexW4387741889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.